SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-24-000893
Filing Date
2024-07-09
Accepted
2024-07-09 06:40:33
Documents
15
Period of Report
2024-07-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e663765_8k-immunic.htm   iXBRL 8-K 27260
2 e663765_ex99-1.htm EX-99.1 17409
6 GRAPHIC image.jpg GRAPHIC 6582
  Complete submission text file 0001193805-24-000893.txt   236805

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE imux-20240709.xsd EX-101.SCH 3003
4 XBRL LABEL FILE imux-20240709_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE imux-20240709_pre.xml EX-101.PRE 22351
17 EXTRACTED XBRL INSTANCE DOCUMENT e663765_8k-immunic_htm.xml XML 3779
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 241106299
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)